Point of Care Testing for Infectious Diseases

Overview

Journal Clin Chim Acta

Specialty Biochemistry

Date 2019 Mar 12

PMID 30853460

Citations 90

Authors

Hui Chen

Kengku Liu

Zhao Li

Ping Wang

Affiliations

Soon will be listed here.

Abstract

Infectious diseases are caused by pathogenic microorganisms and can be transmitted between individuals and populations thus threatening the general public health and potentially the economy. Efficient diagnostic tools are needed to provide accurate and timely guidance for case identification, transmission disruption and appropriate treatment administration. Point of care (POC) tests provide actionable results near the patient and thereby serve as a personal "radar". In this review, we review clinical needs for POC testing for several major pathogens, including malaria parasites, human immunodeficiency virus (HIV), human papillomavirus (HPV), dengue, Ebola and Zika viruses and Mycobacterium tuberculosis (TB). We compare different molecular approaches, including pathogen nucleic acid and protein, circulating microRNA and antibodies, used in the POC tests. Finally, we review recent advances in novel POC technologies focusing on microfluidic and plasmonic-based approaches.

Citing Articles

Innovative Diagnostic Approaches and Challenges in the Management of HIV: Bridging Basic Science and Clinical Practice.

Afzal M, Agarwal S, Elshaikh R, Babker A, Osman E, Choudhary R Life (Basel). 2025; 15(2).

PMID: 40003618 PMC: 11856619. DOI: 10.3390/life15020209.

Clinical performance of real-time nanopore metagenomic sequencing for rapid identification of bacterial pathogens in cerebrospinal fluid: a pilot study.

Sung Y, Ju Y, Lee H, Park S, Suh J, Kim J Sci Rep. 2025; 15(1):3493.

PMID: 39875797 PMC: 11775224. DOI: 10.1038/s41598-025-87858-z.

Reusable Biosensor for Easy RNA Detection from Unfiltered Saliva.

Wityk P, Terebieniec A, Nowak R, Lubinski J, Mroczynska-Szelag M, Wityk T Sensors (Basel). 2025; 25(2).

PMID: 39860729 PMC: 11769206. DOI: 10.3390/s25020360.

Pre-market health systems barriers and enablers to infectious diseases point-of-care diagnostics in Australia: qualitative interviews with key informants.

Lafferty L, Applegate T, Lewis S, Drysdale K, Monaghan R, Kelly-Hanku A BMC Infect Dis. 2024; 24(1):1317.

PMID: 39558237 PMC: 11575463. DOI: 10.1186/s12879-024-10214-5.

Geographical Access to Point-of-care diagnostic tests for diabetes, anaemia, Hepatitis B, and human immunodeficiency virus in the Bono Region, Ghana.

Ansu-Mensah M, Ginindza T, Amponsah S, Shimbre M, Bawontuo V, Kuupiel D BMC Health Serv Res. 2024; 24(1):1303.

PMID: 39472915 PMC: 11520372. DOI: 10.1186/s12913-024-11830-2.

References

Tian L, Tadepalli S, Park S, Liu K, Morrissey J, Kharasch E . Bioplasmonic calligraphy for multiplexed label-free biodetection. Biosens Bioelectron. 2014; 59:208-15. PMC: 4044868. DOI: 10.1016/j.bios.2014.03.043. View

Whitesides G . The origins and the future of microfluidics. Nature. 2006; 442(7101):368-73. DOI: 10.1038/nature05058. View

Garcia-Basteiro A, DiNardo A, Saavedra B, Silva D, Palmero D, Gegia M . Point of care diagnostics for tuberculosis. Pulmonology. 2018; 24(2):73-85. DOI: 10.1016/j.rppnen.2017.12.002. View

Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K . Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2009; 48(1):229-37. PMC: 2812290. DOI: 10.1128/JCM.01463-09. View

Golightly R, Doering W, Natan M . Surface-enhanced Raman spectroscopy and homeland security: a perfect match?. ACS Nano. 2009; 3(10):2859-69. DOI: 10.1021/nn9013593. View

Lu L, Liston A . MicroRNA in the immune system, microRNA as an immune system. Immunology. 2009; 127(3):291-8. PMC: 2712098. DOI: 10.1111/j.1365-2567.2009.03092.x. View

Kaarj K, Akarapipad P, Yoon J . Simpler, Faster, and Sensitive Zika Virus Assay Using Smartphone Detection of Loop-mediated Isothermal Amplification on Paper Microfluidic Chips. Sci Rep. 2018; 8(1):12438. PMC: 6102244. DOI: 10.1038/s41598-018-30797-9. View

Linder V, Sia S, Whitesides G . Reagent-loaded cartridges for valveless and automated fluid delivery in microfluidic devices. Anal Chem. 2004; 77(1):64-71. DOI: 10.1021/ac049071x. View

Lee Y, Lien K, Lei H, Lee G . An integrated microfluidic system for rapid diagnosis of dengue virus infection. Biosens Bioelectron. 2009; 25(4):745-52. PMC: 7125828. DOI: 10.1016/j.bios.2009.08.020. View

10.

Kitahata M, Gange S, Abraham A, Merriman B, Saag M, Justice A . Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009; 360(18):1815-26. PMC: 2854555. DOI: 10.1056/NEJMoa0807252. View

11.

Uludag Y, Tothill I . Cancer biomarker detection in serum samples using surface plasmon resonance and quartz crystal microbalance sensors with nanoparticle signal amplification. Anal Chem. 2012; 84(14):5898-904. DOI: 10.1021/ac300278p. View

12.

Song J, Mauk M, Hackett B, Cherry S, Bau H, Liu C . Instrument-Free Point-of-Care Molecular Detection of Zika Virus. Anal Chem. 2016; 88(14):7289-94. PMC: 4955015. DOI: 10.1021/acs.analchem.6b01632. View

13.

Chen H, Hagstrom A, Kim J, Garvey G, Paterson A, Ruiz-Ruiz F . Flotation Immunoassay: Masking the Signal from Free Reporters in Sandwich Immunoassays. Sci Rep. 2016; 6:24297. PMC: 4830940. DOI: 10.1038/srep24297. View

14.

Magro L, Jacquelin B, Escadafal C, Garneret P, Kwasiborski A, Manuguerra J . Paper-based RNA detection and multiplexed analysis for Ebola virus diagnostics. Sci Rep. 2017; 7(1):1347. PMC: 5431003. DOI: 10.1038/s41598-017-00758-9. View

15.

Robbins P, Morelli A . Regulation of immune responses by extracellular vesicles. Nat Rev Immunol. 2014; 14(3):195-208. PMC: 4350779. DOI: 10.1038/nri3622. View

16.

Wang P, Kricka L . Current and Emerging Trends in Point-of-Care Technology and Strategies for Clinical Validation and Implementation. Clin Chem. 2018; 64(10):1439-1452. DOI: 10.1373/clinchem.2018.287052. View

17.

Chin C, Laksanasopin T, Cheung Y, Steinmiller D, Linder V, Parsa H . Microfluidics-based diagnostics of infectious diseases in the developing world. Nat Med. 2011; 17(8):1015-9. DOI: 10.1038/nm.2408. View

18.

Alizadehrad D, Imai Y, Nakaaki K, Ishikawa T, Yamaguchi T . Quantification of red blood cell deformation at high-hematocrit blood flow in microvessels. J Biomech. 2012; 45(15):2684-9. DOI: 10.1016/j.jbiomech.2012.08.026. View

19.

Busch M, Satten G . Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am J Med. 1997; 102(5B):117-24; discussion 125-6. DOI: 10.1016/s0002-9343(97)00077-6. View

20.

Simon V, Ho D . HIV-1 dynamics in vivo: implications for therapy. Nat Rev Microbiol. 2004; 1(3):181-90. DOI: 10.1038/nrmicro772. View